- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 489/04 - SaltsOrganic complexes
Patent holdings for IPC class C07D 489/04
Total number of patents in this class: 87
10-year publication summary
|
20
|
7
|
15
|
9
|
4
|
3
|
4
|
3
|
1
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Zevra Therapeutics, Inc. | 99 |
17 |
| Macfarlan Smith Limited | 97 |
8 |
| Nektar Therapeutics | 435 |
8 |
| Mallinckrodt Inc. | 171 |
4 |
| Progenics Pharmaceuticals, Inc. | 128 |
4 |
| SpecGx LLC | 183 |
4 |
| Alere San Diego, Inc. | 63 |
3 |
| Mallinckrodt LLC | 132 |
3 |
| Penick Corporation | 7 |
3 |
| Wyeth LLC | 650 |
2 |
| Cambrex Charles City, Inc. | 17 |
2 |
| Memorial Sloan-Kettering Cancer Center | 1929 |
2 |
| Alar Pharmaceuticals, Inc. | 6 |
2 |
| Noramco, LLC | 27 |
2 |
| Lawrence Livermore National Security, LLC | 1937 |
1 |
| Arete Therapeutics, Inc. | 23 |
1 |
| Brock University | 60 |
1 |
| Chulalongkorn University | 40 |
1 |
| Ferrer Internacional, S.A. | 278 |
1 |
| Grünenthal GmbH | 569 |
1 |
| Other owners | 17 |